The honest position on SLU-PP-332 side effects is the simplest one in this reference: they are unknown, because the compound has never been tested in humans. There is no clinical safety dataset of any kind for people.[1][2]
Reviewed for accuracy · Last reviewed July 7, 2026The available research is entirely preclinical and focused on efficacy-style outcomes in mice (endurance, energy expenditure, fat mass, insulin sensitivity) rather than a human adverse-event profile. Because it is a small-molecule research chemical rather than an approved medicine, both its biological effects and its product quality in humans are uncharacterized. Anyone treating mouse results as a safety signal is over-reading the evidence.
There is no human safety information to manage against. The cautious reading is that the unknowns are near-total for people, since no human has been studied.
This page is an independent educational reference and is not medical advice, and does not indicate any approval status for any use. SLU-PP-332 is a preclinical compound not tested in humans.